Anne Gussow

Array ( [id] => 7038890 [patent_doc_number] => 20050158324 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-07-21 [patent_title] => 'Methods of therapy and diagnosis using targeting of cells that express BCLP polypeptides' [patent_app_type] => utility [patent_app_number] => 11/014487 [patent_app_country] => US [patent_app_date] => 2004-12-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 30498 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0158/20050158324.pdf [firstpage_image] =>[orig_patent_app_number] => 11014487 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4619351 [patent_doc_number] => 07999071 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-08-16 [patent_title] => 'Human cytotoxic T-lymphoctye epitope and its agonist eptiope from the non-variable number of tandem repeat sequence of MUC-1' [patent_app_type] => utility [patent_app_number] => 10/582702 [patent_app_country] => US [patent_app_date] => 2004-12-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 11 [patent_no_of_words] => 38329 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/999/07999071.pdf [firstpage_image] =>[orig_patent_app_number] => 10582702 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5010472 [patent_doc_number] => 20070280951 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-12-06 [patent_title] => 'Cell Death Inducing Agents' [patent_app_type] => utility [patent_app_number] => 10/582304 [patent_app_country] => US [patent_app_date] => 2004-12-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 11135 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0280/20070280951.pdf [firstpage_image] =>[orig_patent_app_number] => 10582304 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5613553 [patent_doc_number] => 20060115481 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-01 [patent_title] => 'Method of treating tumor growth and metastasis by using trifunctional antibodies to reduce the risk for GvHD in allogeneic antitumor cell therapy' [patent_app_type] => utility [patent_app_number] => 11/000484 [patent_app_country] => US [patent_app_date] => 2004-11-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 9826 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0115/20060115481.pdf [firstpage_image] =>[orig_patent_app_number] => 11000484 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5215634 [patent_doc_number] => 20070104715 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-05-10 [patent_title] => 'Antibodies binding to a c-terminal fragment of apoliopoprotein e' [patent_app_type] => utility [patent_app_number] => 10/579445 [patent_app_country] => US [patent_app_date] => 2004-11-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 31 [patent_no_of_words] => 55152 [patent_no_of_claims] => 53 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0104/20070104715.pdf [firstpage_image] =>[orig_patent_app_number] => 10579445 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 571167 [patent_doc_number] => 07462697 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-12-09 [patent_title] => 'Methods for antibody engineering' [patent_app_type] => utility [patent_app_number] => 10/984473 [patent_app_country] => US [patent_app_date] => 2004-11-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 15624 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 225 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/462/07462697.pdf [firstpage_image] =>[orig_patent_app_number] => 10984473 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7801234 [patent_doc_number] => 08129506 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-03-06 [patent_title] => 'Modulation of the interaction of MUC1 with MUC1 ligands' [patent_app_type] => utility [patent_app_number] => 10/577003 [patent_app_country] => US [patent_app_date] => 2004-10-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16623 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/129/08129506.pdf [firstpage_image] =>[orig_patent_app_number] => 10577003 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4976821 [patent_doc_number] => 20070218052 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-09-20 [patent_title] => 'Novel lgG3 Antibodies for Stimulating Phagocytosis' [patent_app_type] => utility [patent_app_number] => 10/575218 [patent_app_country] => US [patent_app_date] => 2004-10-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 4973 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0218/20070218052.pdf [firstpage_image] =>[orig_patent_app_number] => 10575218 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5290008 [patent_doc_number] => 20090022738 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-01-22 [patent_title] => 'Multispecific deimmunized CD3-binders' [patent_app_type] => utility [patent_app_number] => 10/572740 [patent_app_country] => US [patent_app_date] => 2004-10-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 41 [patent_figures_cnt] => 41 [patent_no_of_words] => 35134 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0022/20090022738.pdf [firstpage_image] =>[orig_patent_app_number] => 10572740 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 167861 [patent_doc_number] => 07666605 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-02-23 [patent_title] => 'Method for prognostic evaluation of carcinoma using anti-P-LAP antibody' [patent_app_type] => utility [patent_app_number] => 10/575763 [patent_app_country] => US [patent_app_date] => 2004-09-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 3861 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 82 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/666/07666605.pdf [firstpage_image] =>[orig_patent_app_number] => 10575763 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6951787 [patent_doc_number] => 20050226881 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-10-13 [patent_title] => 'Isolated peptide which binds to HLA-Cw*07 and uses thereof' [patent_app_type] => utility [patent_app_number] => 10/941150 [patent_app_country] => US [patent_app_date] => 2004-09-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8927 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0226/20050226881.pdf [firstpage_image] =>[orig_patent_app_number] => 10941150 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7233946 [patent_doc_number] => 20050079553 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-04-14 [patent_title] => 'SSX-2 peptides presented by HLA class II molecules' [patent_app_type] => utility [patent_app_number] => 10/937794 [patent_app_country] => US [patent_app_date] => 2004-09-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 33436 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0079/20050079553.pdf [firstpage_image] =>[orig_patent_app_number] => 10937794 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5119347 [patent_doc_number] => 20070141061 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-06-21 [patent_title] => 'Protein involved in carcinoma' [patent_app_type] => utility [patent_app_number] => 10/569234 [patent_app_country] => US [patent_app_date] => 2004-08-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 17345 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0141/20070141061.pdf [firstpage_image] =>[orig_patent_app_number] => 10569234 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4994164 [patent_doc_number] => 20070009509 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-01-11 [patent_title] => 'Antibody against nox1 polypeptide, method of diagnosing cancer with the use of nox1 gene and method of screening cancer growth inhibitor' [patent_app_type] => utility [patent_app_number] => 10/570011 [patent_app_country] => US [patent_app_date] => 2004-08-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 10530 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0009/20070009509.pdf [firstpage_image] =>[orig_patent_app_number] => 10570011 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5642634 [patent_doc_number] => 20060281089 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-12-14 [patent_title] => 'Methods for detecting cancer and monitoring cancer progression' [patent_app_type] => utility [patent_app_number] => 10/559232 [patent_app_country] => US [patent_app_date] => 2004-06-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 11156 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0281/20060281089.pdf [firstpage_image] =>[orig_patent_app_number] => 10559232 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 463124 [patent_doc_number] => 07238524 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-07-03 [patent_title] => 'Prostate cancer cell lines' [patent_app_type] => utility [patent_app_number] => 10/862256 [patent_app_country] => US [patent_app_date] => 2004-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 19 [patent_no_of_words] => 5411 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 112 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/238/07238524.pdf [firstpage_image] =>[orig_patent_app_number] => 10862256 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8257833 [patent_doc_number] => 08207311 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-06-26 [patent_title] => 'Ovr115 antibody compositions and methods of use' [patent_app_type] => utility [patent_app_number] => 10/556478 [patent_app_country] => US [patent_app_date] => 2004-05-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 38 [patent_no_of_words] => 50598 [patent_no_of_claims] => 46 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 10556478 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5177041 [patent_doc_number] => 20070178101 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-08-02 [patent_title] => 'Ovr110 antibody compositions and methods of use' [patent_app_type] => utility [patent_app_number] => 10/557331 [patent_app_country] => US [patent_app_date] => 2004-05-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 45883 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0178/20070178101.pdf [firstpage_image] =>[orig_patent_app_number] => 10557331 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5182548 [patent_doc_number] => 20070053894 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-03-08 [patent_title] => 'Compound and method for regulating plasminogen activation and cell migration' [patent_app_type] => utility [patent_app_number] => 10/556145 [patent_app_country] => US [patent_app_date] => 2004-05-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 33 [patent_figures_cnt] => 33 [patent_no_of_words] => 18308 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0053/20070053894.pdf [firstpage_image] =>[orig_patent_app_number] => 10556145 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 270363 [patent_doc_number] => 07563599 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-07-21 [patent_title] => 'Reshaped human antibody to human medulloblastoma cells' [patent_app_type] => utility [patent_app_number] => 10/839799 [patent_app_country] => US [patent_app_date] => 2004-05-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 13640 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 146 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/563/07563599.pdf [firstpage_image] =>[orig_patent_app_number] => 10839799 [rel_patent_id] =>[rel_patent_doc_number] =>)